Cirrhotic Ascites
4 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Phase II/III Clinical Trial of Recombinant Human Serum Albumin in Cirrhotic Patients With Ascites (NCT06553456) | Protgen Ltd | 2024-08-19 |
| Phase II/III of Recombinant Human Serum Albumin (NCT05858853) | Protgen Ltd | 2023-05-24 |
| A Phase II Study of OsrHSA in Patients With Decompensated Cirrhotic Ascites (NCT04835480) | Healthgen Biotechnology Corp. | 2021-03-22 |
| Study of Efficacy of a Vasopressin 2 Receptor Antagonist M0002 for Treatment of Ascites in Cirrhotic Subjects With Hypo- or Normonatraemia (NCT01179607) | Movetis | 2007-06-01 |
Track Cirrhotic Ascites automatically
Every clearance here is in the API, with alerts when new ones post.